According to statistics, cancer incidence and mortality rates continue to increase worldwide, with more than half of the cases occurring in less developed regions. Detecting cancer early, before it becomes malignant or metastasized, remains the best strategy for reducing cancer deaths. The implementation of early detection could potentially save ~3.5 million lives every year, and the use of an accurate and efficient screening tool is more critical than ever before.
Specifically designed for early colon cancer detection, the IntelliPlexTM Colon Cancer Screening Kit (under development) incorporating the SelectAmp Technology can simultaneously detect all hotspot mutations in 4 genes (15 mutations) in a multiplexing assay. Our kit provides a non-invasive, ultrasensitive, multiplexing tool to concurrently detect gene mutations related to colon cancer.